Question to the Ministry of Defence:

To ask the Secretary of State for Defence, pursuant to the Answer of 15 March 2022 to Question 136649 on Armed Forces: HIV infection, for what reason the updated policy cannot be published before August 2022.

Seemingly innocuous medication side effects can have serious safety implications in the military aviation context. Consequently, approving medication use in aviation is a rigorous, evidence-based process involving a number of pharmacists, medical and aviation experts. The process ensures benchmarking with other military organisations and civilian counterparts.

This extensive process is currently underway to approve PrEP and it is expected to result in revised policy being published in August 2022. The aspiration is to publish sooner if possible and the process is currently being advanced to achieve this.